5-HT(1B) Autoreceptor Regulation of Serotonin Transporter Activity in Synaptosomes

Overview

Journal Synapse

Specialty Neurology

Date 2012 Sep 11

PMID 22961814

Citations 29

Authors

Catherine E Hagan

Ross A McDevitt

Yusha Liu

Amy R Furay

John F Neumaier

Affiliations

Soon will be listed here.

Abstract

Serotonin-1B (5-HT(1B) ) autoreceptors are located in serotonin (5-HT) terminals, along with serotonin transporters (SERT), and play a critical role in autoregulation of serotonergic neurotransmission and are implicated in disorders of serotonergic function, particularly emotional regulation. SERT modulates serotonergic neurotransmission by high-affinity reuptake of 5-HT. Alterations in SERT activity are associated with increased risk for depression and anxiety. Several neurotransmitter receptors are known to regulate SERT K(m) and V(max) , and previous work suggests that 5-HT(1B) autoreceptors may regulate 5-HT reuptake, in addition to modulating 5-HT release and synthesis. We used rotating disk electrode voltammetry to investigate 5-HT(1B) autoreceptor regulation of SERT-mediated 5-HT uptake into synaptosomes. The selective 5-HT(1B) antagonist SB224289 decreased SERT activity in synaptosomes prepared from wild-type but not 5-HT(1B) knockout mice, whereas SERT uptake was enhanced after pretreatment with the selective 5-HT(1B) agonist CP94253. Furthermore, SERT activity varies as a function of 5-HT(1B) receptor expression-specifically, genetic deletion of 5-HT(1B) decreased SERT function, while viral-mediated overexpression of 5-HT(1B) autoreceptors in rat raphe neurons increased SERT activity in rat hippocampal synaptosomes. Considered collectively, these results provide evidence that 5-HT(1B) autoreceptors regulate SERT activity. Because SERT clearance rate varies as a function of 5-HT(1B) autoreceptor expression levels and is modulated by both activation and inhibition of 5-HT(1B) autoreceptors, this dynamic interaction may be an important mechanism of serotonin autoregulation with therapeutic implications.

Citing Articles

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms.

Hassan M, Flanagan T, Eshaq A, Altamimi O, Altalag H, Alsharif M Cancers (Basel). 2025; 17(5).

PMID: 40075690 PMC: 11898507. DOI: 10.3390/cancers17050843.

Use of vortioxetine in different neurological fields: a systematic review and future perspectives.

Verrienti G, Colonna I, Raccagni C Neurol Sci. 2025; .

PMID: 39808348 DOI: 10.1007/s10072-025-07987-1.

Serotonin acts through multiple cellular targets during an olfactory critical period.

Mallick A, Tan H, Epstein J, Jing Ng C, Cook O, Gaudry Q iScience. 2024; 27(11):111083.

PMID: 39524339 PMC: 11550141. DOI: 10.1016/j.isci.2024.111083.

Increased expression of mesencephalic astrocyte-derived neurotrophic factor (MANF) contributes to synapse loss in Alzheimer's disease.

Zhang Y, Chen X, Chen L, Shao M, Zhu W, Xing T Mol Neurodegener. 2024; 19(1):75.

PMID: 39425207 PMC: 11490049. DOI: 10.1186/s13024-024-00771-3.

Modulation of serotonin transporter expression by escitalopram under inflammation.

Mena S, Cruikshank A, Best J, Nijhout H, Reed M, Hashemi P Commun Biol. 2024; 7(1):710.

PMID: 38851804 PMC: 11162477. DOI: 10.1038/s42003-024-06240-3.

References

Morecroft I, Loughlin L, Nilsen M, Colston J, Dempsie Y, Sheward J . Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries. J Pharmacol Exp Ther. 2005; 313(2):539-48. DOI: 10.1124/jpet.104.081182. View

Sarhan H, Fillion G . Differential sensitivity of 5-HT1B auto and heteroreceptors. Naunyn Schmiedebergs Arch Pharmacol. 1999; 360(4):382-90. DOI: 10.1007/s002109900067. View

Iversen L . Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol. 1971; 41(4):571-91. PMC: 1702772. DOI: 10.1111/j.1476-5381.1971.tb07066.x. View

Daws L . Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther. 2008; 121(1):89-99. PMC: 2739988. DOI: 10.1016/j.pharmthera.2008.10.004. View

Vertes R, Fortin W, Crane A . Projections of the median raphe nucleus in the rat. J Comp Neurol. 1999; 407(4):555-82. View

McDevitt R, Hiroi R, MacKenzie S, Robin N, Cohn A, Kim J . Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. Biol Psychiatry. 2011; 69(8):780-7. PMC: 3080128. DOI: 10.1016/j.biopsych.2010.12.029. View

Trillat A, Malagie I, Scearce K, Pons D, Anmella M, Jacquot C . Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies. J Neurochem. 1998; 69(5):2019-25. DOI: 10.1046/j.1471-4159.1997.69052019.x. View

Kaiyala K, Vincow E, Sexton T, Neumaier J . 5-HT1B receptor mRNA levels in dorsal raphe nucleus: inverse association with anxiety behavior in the elevated plus maze. Pharmacol Biochem Behav. 2003; 75(4):769-76. DOI: 10.1016/s0091-3057(03)00152-7. View

Blakely R, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A . Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry. 1998; 44(3):169-78. DOI: 10.1016/s0006-3223(98)00124-3. View

10.

Steiner J, Carneiro A, Blakely R . Going with the flow: trafficking-dependent and -independent regulation of serotonin transport. Traffic. 2008; 9(9):1393-402. PMC: 2773847. DOI: 10.1111/j.1600-0854.2008.00757.x. View

11.

Amara S, Sonders M . Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend. 1998; 51(1-2):87-96. DOI: 10.1016/s0376-8716(98)00068-4. View

12.

Hoyer D, Middlemiss D . Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol Sci. 1989; 10(4):130-2. DOI: 10.1016/0165-6147(89)90159-4. View

13.

Sarhan H, Cloez-Tayarani I, Massot O, Fillion M, Fillion G . 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes. Naunyn Schmiedebergs Arch Pharmacol. 1999; 359(1):40-7. DOI: 10.1007/pl00005321. View

14.

Lawrie A, Spiekerkoetter E, Martinez E, Ambartsumian N, Sheward W, MacLean M . Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ Res. 2005; 97(3):227-35. DOI: 10.1161/01.RES.0000176025.57706.1e. View

15.

Gardier A . Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor. Behav Pharmacol. 2009; 20(1):18-32. DOI: 10.1097/FBP.0b013e3283243fcd. View

16.

Quick M . Regulating the conducting states of a mammalian serotonin transporter. Neuron. 2003; 40(3):537-49. DOI: 10.1016/s0896-6273(03)00605-6. View

17.

Stamford J, Davidson C, McLaughlin D, Hopwood S . Control of dorsal raphé 5-HT function by multiple 5-HT(1) autoreceptors: parallel purposes or pointless plurality?. Trends Neurosci. 2000; 23(10):459-65. DOI: 10.1016/s0166-2236(00)01631-3. View

18.

Selkirk J, Scott C, Ho M, Burton M, Watson J, Gaster L . SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Br J Pharmacol. 1998; 125(1):202-8. PMC: 1565605. DOI: 10.1038/sj.bjp.0702059. View

19.

Neumaier J, Edwards E, Plotsky P . 5-HT(1B) mrna regulation in two animal models of altered stress reactivity. Biol Psychiatry. 2002; 51(11):902-8. DOI: 10.1016/s0006-3223(01)01371-3. View

20.

Daws L, Gould G . Ontogeny and regulation of the serotonin transporter: providing insights into human disorders. Pharmacol Ther. 2011; 131(1):61-79. PMC: 3131109. DOI: 10.1016/j.pharmthera.2011.03.013. View